'- Q2 Revenue of $7.6 Billion Decreased 0.8% Reported and 1.5% Organic - Q2 GAAP Diluted EPS of $0.36; Q2 Non-GAAP Diluted EPS of $1.02 DUBLIN, Nov. 24, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) today announced financial results for its second...
Analysis of more than 16,000 lumbar fusion procedures showed similar clinical outcomes with average hospital fees up to $50,000 lower using ViviGen. VIRGINIA BEACH, Va., Nov. 23, 2020 /PRNewswire/ -- ViviGen® Cellular Bone Matrix is associated...
Partnership Expands Exactech’s Active Intelligence® Portfolio of Smart Solutions. GAINESVILLE, Fla. & QUEBEC CITY--(BUSINESS WIRE)--Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced...
-- Becker's Spine listed Centinel Spine as the top Orthopedic Solution Company in 2020 -- Becker's Spine referenced MedTech Outlook as the source behind the recognition of innovators at the forefront...
NEW YORK, Nov. 23, 2020 /PRNewswire/ -- A novel approach to spinal fusion surgery results in a reduction of blood loss during surgery and less ileus, or intestinal blockage, postoperatively, as well...
DEERFIELD, Ill., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc. (Nasdaq: SRGA), a global pure-play spine company focused on advancing spine surgery including through the application of digital technologies...
Royalty income from licensed demineralized bone fiber technologies has surpassed $1.0m annually. LOS ANGELES, Nov. 20, 2020 /PRNewswire/ -- TheraCell Inc., a leading allograft solution company, today announced that as of September 30, 2020 its royalty income...
Provides enhancements to TSolution One® Total Knee Application currently in use in hospitals and ambulatory surgery centers in the United States FREMONT, Calif., Nov. 20, 2020 /PRNewswire/ -- THINK Surgical, an innovator in the...
MELVILLE, N.Y., Nov. 20, 2020 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative” or the “Company”) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, announced today that its...
UDINE, Italy, Nov. 19, 2020 /PRNewswire/ -- LimaCorporate is proud to announce that the U.S. Food and Drug Administration (FDA) has approved the Investigational Device Exemption (IDE) to start the clinical trial of...